Company Filing History:
Years Active: 1998-2002
Title: **Patricia A. Moran: Pioneering Innovations in HIV Research**
Introduction
Patricia A. Moran, based in Seattle, Washington, is a notable inventor with a focus on innovations that address significant health challenges, particularly in the realm of HIV research. With three patents to her name, her contributions have the potential to make a lasting impact on the treatment of HIV-1 infections.
Latest Patents
One of Patricia’s latest patents revolves around "Methods for inhibiting the production of HIV-1 retrovirus using monoclonal antibodies and Fv specific for CD2 antigen." This invention includes an anti-CD2 monoclonal antibody that can be a chimeric nonclonal antibody CD2 SFv-Ig produced through recombinant culture. The invention outlines various embodiments, including monoclonal antibodies that compete with CD2 SFv-Ig for binding to the CD2 antigen. These innovations are intended to inhibit the production of HIV-1 by HIV-1-infected T cells and can also be utilized to treat AIDS patients by reinfusing treated T cells to enhance their immune response.
Career Highlights
Patricia A. Moran works at Bristol-Myers Squibb Company, where she collaborates with other accomplished professionals in the field. Her work focuses on developing scientific solutions that can lead to improved therapies for HIV-1 infection. Her commitment to research in this critical area solidifies her role as a prominent figure in the scientific community.
Collaborations
Throughout her career, Patricia has collaborated with colleagues such as Michael L. Diegel and Lisa K. Gilliland, enhancing the innovation process through teamwork and shared expertise. These collaborations are pivotal in driving forward the research and development that can lead to practical applications of her patented inventions.
Conclusion
In summary, Patricia A. Moran stands out as a dedicated inventor whose work in HIV-1 research is crucial for advancing medical treatments. With her innovative patents and collaborative spirit, she continues to contribute to significant advancements in the fight against this global health crisis. Her efforts not only reflect her commitment to science but also her desire to improve human health outcomes.